GQG Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,155,111
Closed -$105M 48
2019
Q1
$105M Sell
1,155,111
-862,664
-43% -$77.2M 1.31% 23
2018
Q4
$184M Buy
2,017,775
+797,126
+65% +$74.5M 2.83% 14
2018
Q3
$120M Buy
1,220,649
+390,642
+47% +$36.1M 1.95% 20
2018
Q2
$64.9M Buy
830,007
+547,989
+194% +$45.8M 1.55% 24
2018
Q1
$22.6M Buy
282,018
+109,182
+63% +$9.01M 0.59% 38
2017
Q4
$14M Sell
172,836
-102,911
-37% -$8.24M 0.44% 39
2017
Q3
$21.4M Buy
275,747
+226,259
+457% +$18.8M 0.75% 33
2017
Q2
$4.39M Buy
+49,488
New +$4.17M 0.32% 37

Other funds holding MDT

GQG Partners's MDT Position: Q2 2019 in Review

GQG Partners sold out of Medtronic (MDT) in Q2 2019, closing a stake of 1,155,111 shares — an estimated $105M sold.

GQG Partners first reported a position in MDT in Q2 2017 and held it in 8 quarters. The position peaked at $184M in Q4 2018. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

  • GQG Partners reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
  • GQG Partners sold 1,155,111 Medtronic shares in Q2 2019, an estimated $105M.
  • GQG Partners first reported a position in Medtronic in Q2 2017 and held it in 8 quarters.
  • GQG Partners's Medtronic position peaked at $184M in Q4 2018.
  • 1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on GQG Partners's 13F filing for Q2 2019, filed 14 Aug 2019.